Portrait of Kanav Jain

Product leader · hands-on builder · Chicago · Open to relocation

I turn new AI capabilities into products that hospitals and other cautious institutions will deploy

calls on an average workday
300,000+
health systems using it
250+
since I left, still running
9 years

Doximity Dialer, which I originated as founding product lead. Doximity’s own figures, February 2026.

14 years as a product leader and hands-on builder, making products in clinical care, oncology and AI, after training in biomedical engineering and molecular-biology research. See where I’d fit →

DoximityEpicTranscarentCancerCompass / CTCA MarketplaceAndwiseMemorial Sloan Kettering Cancer CenterTechstars

The two products deal with one problem: records that go out of date while people still rely on them, like a guideline that no longer matches the evidence.

  • Refract Change tracking: records every edit to a source, such as a Wikipedia article, and what each edit changed. A published test set of 16,146 recorded edits, reproducible from the same source.
  • Fast Harm, Slow Repair Agent error evaluation: a draft benchmark protocol for measuring how far AI mistakes propagate through tools and what remains wrong after correction. No results yet.

I come in before there’s a roadmap, build an unproven idea far enough to see whether it holds, and then decide what to scale, what to cut, and who should own it.

I originated Doximity Dialer, led R&D at CancerCompass, and co-founded Andwise. Andwise validated strong physician demand in year one, but the fundable paths in year two conflicted with serving physicians directly. In 2024, I chose to wind down the company rather than compromise that fiduciary alignment. Since then I have focused on hands-on systems building, validating new AI capabilities in working software before scaling them through teams.

Revised